Transcatheter tricuspid valve intervention: Current perspective

Trevor J. Simard, Mackram F. Eleid

Research output: Contribution to journalArticlepeer-review


Tricuspid regurgitation (TR) adversely impacts both quality of life and long-term survival, which generates interest in therapeutic approaches to mitigate these effects. Historically, therapeutic options for TR were limited to surgical approaches, which are often complicated by significant morbidity and mortality in elderly patients with multiple comorbidities. This gap in therapeutic options led to the rapid evolution of transcatheter tricuspid valve intervention (TTVI), with a wide variety of approaches pursued and early results suggesting that TTVI improves clinical outcomes. Numerous strategies, including edge-to-edge repair, annular reduction, spacers, caval valve implantation, and transcatheter tricuspid valve replacement form the basis of TTVI today. In this review, the authors discuss the current state of each approach.

Original languageEnglish (US)
Article numbere12
JournalUS Cardiology Review
StatePublished - 2021


  • TTVI
  • TTVR
  • Transcatheter
  • Tricuspid regurgitation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Transcatheter tricuspid valve intervention: Current perspective'. Together they form a unique fingerprint.

Cite this